Global Point of Care Coagulation Testing Products Market
Description
MARKET SCOPE:
The global point of care coagulation testing products market is projected to grow significantly, registering a CAGR of 6.5% during the forecast period (2026 – 2034).
The point of care coagulation testing products market growth is driven by the increasing global prevalence of cardiovascular diseases and bleeding disorders, and the growing demand for rapid, accurate diagnostic solutions. The consumables and instruments employed for these tests are in demand due to frequent use and the need for real-time results, especially in critical and emergency situations. Technological advancements in mechanical, electrochemical, and optical technologies have enhanced the sensitivity and user friendliness of these devices, thus facilitating their uptake in various healthcare settings. The increasing demand for minimally invasive and patient-focused diagnostics also fuels the market, especially in the prothrombin time and activated clotting time segments, which are critical for anticoagulation therapy monitoring.
The market is also benefiting from the expansion of point-of-care testing settings beyond traditional hospital and laboratory environments. Portable and user-friendly instruments now allow for accurate coagulation testing in outpatient clinics, homecare settings, and remote areas, supporting broader accessibility and faster clinical decisions. The integration of digital health technologies and connectivity features in testing devices enables better monitoring and data management, thus enhancing clinical workflow efficiency. Moreover, supportive government policies and reimbursement frameworks, especially in developed regions, are incentivizing healthcare providers to adopt point-of-care coagulation testing solutions, driving further growth across hospitals, clinical laboratories, and decentralized testing centers.
MARKET OVERVIEW:
Driver: Increasing Prevalence of Cardiovascular Disorders Driving Point-of-Care Coagulation Testing Demand
The growing incidence of cardiovascular diseases, blood clotting disorders, and conditions requiring anticoagulant therapy is a key driver for the point of care coagulation testing products market. With patients needing frequent monitoring of clotting parameters such as prothrombin time and activated clotting time, the demand for fast, reliable diagnostic solutions is increasing. These tests are especially valuable in emergency and critical care settings, where time-sensitive decisions are crucial. The ability of point-of-care devices to deliver immediate results at the bedside improves treatment outcomes and reduces hospital stays.
Additionally, the aging global population, which is more susceptible to such conditions, is contributing to the steady demand for coagulation testing. Healthcare providers are increasingly integrating point-of-care devices into their workflow to enhance efficiency, reduce lab dependency, and provide faster diagnoses. This has led to broader adoption across hospitals, clinics, and even outpatient care settings, further strengthening market growth.
Restraint: High Costs of Advanced Testing Devices Limiting Widespread Adoption
Despite their clinical benefits, the high cost associated with point-of-care coagulation testing instruments and consumables remains a major barrier to adoption. Sophisticated devices with advanced technologies such as optical and electrochemical detection are expensive, both in terms of upfront investment and recurring consumable use. This financial burden is especially challenging for smaller healthcare facilities, rural clinics, and institutions in low- to middle-income countries.
In addition, limited reimbursement policies in some regions discourage healthcare providers from investing in these devices. Maintenance costs, training requirements, and lack of standardization in testing practices can also hinder widespread use. As a result, cost remains a critical restraint, preventing universal access to these life-saving diagnostic tools.
Opportunities: Expansion into Home-Based and Remote Coagulation Monitoring
The rise of home healthcare and remote patient monitoring presents a promising opportunity for the point of care coagulation testing market. As healthcare systems shift toward more patient-centric and decentralized care models, compact and user-friendly coagulation testing devices are gaining traction for at-home use. Patients on long-term anticoagulation therapy can benefit from frequent self-monitoring without frequent hospital visits, reducing costs and improving quality of life.
Technological advancements, such as wireless connectivity and mobile health apps, further support remote diagnostics by allowing real-time data sharing between patients and healthcare providers. This facilitates better management of chronic conditions, early intervention, and enhanced compliance. As digital health continues to evolve, manufacturers focusing on portable, connected, and easy-to-use devices will unlock new market segments and drive the next phase of growth in coagulation testing.
SEGMENTATION ANALYSIS:
The consumables segment is anticipated to grow significantly during the forecast period
The consumables segment in the point of care coagulation testing products market is expected to maintain its dominant position during the forecast period, driven by the consistent and recurring need for test strips, reagents, and other disposable components. As these consumables are essential for each test conducted across hospitals, clinics, and home care settings, their usage volume remains significantly high. The growing patient base requiring regular monitoring of coagulation levels—especially those undergoing anticoagulant therapy—further accelerates demand. Additionally, advancements in consumable efficiency and accuracy, along with their relatively low cost compared to instruments, contribute to their widespread adoption and revenue generation.
The instruments segment, while accounting for a smaller share, plays a critical role in supporting point of care testing by enabling fast and accurate blood coagulation analysis. These devices, including portable analyzers and compact benchtop systems, are becoming increasingly sophisticated with features like digital connectivity and integration with electronic health records. However, the high initial investment and lower frequency of replacement restrain rapid growth. Despite this, the rising use of these instruments in emergency care, operating rooms, and remote monitoring is expected to support steady growth, especially as healthcare providers move toward decentralized and technology-driven diagnostic solutions.
REGIONAL ANALYSIS:
The North America region is set to witness significant growth during the forecast period.
North America currently dominates the point of care coagulation testing products market, owing to its advanced healthcare infrastructure, high adoption of innovative medical technologies, and strong presence of key industry players. The region benefits from well-established diagnostic protocols, favorable reimbursement policies, and a high prevalence of cardiovascular and bleeding disorders, which necessitate frequent coagulation monitoring. The widespread availability of point-of-care devices across hospitals, outpatient clinics, and emergency departments supports rapid clinical decision-making, further strengthening market penetration. Moreover, increasing awareness of early disease detection and the growing trend of decentralized healthcare delivery continue to fuel the demand for both consumables and instruments in the region.
Moreover, Asia-Pacific is projected to be the fastest-growing region in the point of care coagulation testing market during the forecast period. This growth is driven by a rising aging population, increasing healthcare expenditures, and a surge in chronic disease prevalence, particularly in countries like China, India, and Japan. The growing focus on expanding rural healthcare access, along with government initiatives to improve diagnostic services, is creating new opportunities for market players. In addition, the shift toward home healthcare and the adoption of portable diagnostic devices are gaining momentum across the region. As awareness and affordability continue to rise, Asia Pacific is poised to become a key market for point of care coagulation testing solutions in the coming years.
COMPETITIVE ANALYSIS:
The global point of care coagulation testing products market is reasonably competitive with mergers, acquisitions, and product launches. See some of the major key players in the market.
F. Hoffmann-La Roche Ltd
Abbott Laboratories
Thermo Fischer Scientific
Siemens Healthineers
International Technidyne Corporation
Beckman Coulter Inc
Instrumentation Laboratory
Sysmex Corporation
Meril Life Sciences Pvt. Ltd
Helena Laboratories
OraSure Technologies
LifeScan IP Holdings LLC
Recent Development of these Companies:
In July 2024, F. Hoffmann-La Roche Ltd launched three new coagulation tests for oral Factor Xa inhibitors—apixaban, edoxaban, and rivaroxaban—in countries accepting the CE mark, enhancing patient care for those on these anticoagulants.
In July 2024, Roche completed the acquisition of LumiraDx's point-of-care technology, aiming to expand access to diagnostic testing in primary care settings.
In 2024, Abbott Laboratories showcased its end-to-end laboratory solutions at the ADLM Clinical Lab Expo, highlighting advancements in point-of-care testing technologies.
In 2024, Thermo Fisher Scientific highlighted its diagnostics innovations across therapeutic areas at ADLM 2024, emphasizing advancements in point-of-care testing solutions.
SCOPE OF THE REPORT:
By Product Type
It provides a technological development map over time to understand the industry’s growth rate and indicates how the Point of Care Coagulation Testing Products Market is evolving.
The report offers a dynamic method to various factors that drive or restrain the growth of the market and specifies which Point of Care Coagulation Testing Products submarket will be the main driver of the overall market from 2026 to 2034.
It renders a definite analysis of changing competitive dynamics and stipulates the leading players and what are their prospects over the forecast period.
It builds a nine-year estimate based on how the market is predicted to grow and shows what will market shares of the global region change by 2034 and which country will lead the market in 2034.
The global point of care coagulation testing products market is projected to grow significantly, registering a CAGR of 6.5% during the forecast period (2026 – 2034).
The point of care coagulation testing products market growth is driven by the increasing global prevalence of cardiovascular diseases and bleeding disorders, and the growing demand for rapid, accurate diagnostic solutions. The consumables and instruments employed for these tests are in demand due to frequent use and the need for real-time results, especially in critical and emergency situations. Technological advancements in mechanical, electrochemical, and optical technologies have enhanced the sensitivity and user friendliness of these devices, thus facilitating their uptake in various healthcare settings. The increasing demand for minimally invasive and patient-focused diagnostics also fuels the market, especially in the prothrombin time and activated clotting time segments, which are critical for anticoagulation therapy monitoring.
The market is also benefiting from the expansion of point-of-care testing settings beyond traditional hospital and laboratory environments. Portable and user-friendly instruments now allow for accurate coagulation testing in outpatient clinics, homecare settings, and remote areas, supporting broader accessibility and faster clinical decisions. The integration of digital health technologies and connectivity features in testing devices enables better monitoring and data management, thus enhancing clinical workflow efficiency. Moreover, supportive government policies and reimbursement frameworks, especially in developed regions, are incentivizing healthcare providers to adopt point-of-care coagulation testing solutions, driving further growth across hospitals, clinical laboratories, and decentralized testing centers.
MARKET OVERVIEW:
Driver: Increasing Prevalence of Cardiovascular Disorders Driving Point-of-Care Coagulation Testing Demand
The growing incidence of cardiovascular diseases, blood clotting disorders, and conditions requiring anticoagulant therapy is a key driver for the point of care coagulation testing products market. With patients needing frequent monitoring of clotting parameters such as prothrombin time and activated clotting time, the demand for fast, reliable diagnostic solutions is increasing. These tests are especially valuable in emergency and critical care settings, where time-sensitive decisions are crucial. The ability of point-of-care devices to deliver immediate results at the bedside improves treatment outcomes and reduces hospital stays.
Additionally, the aging global population, which is more susceptible to such conditions, is contributing to the steady demand for coagulation testing. Healthcare providers are increasingly integrating point-of-care devices into their workflow to enhance efficiency, reduce lab dependency, and provide faster diagnoses. This has led to broader adoption across hospitals, clinics, and even outpatient care settings, further strengthening market growth.
Restraint: High Costs of Advanced Testing Devices Limiting Widespread Adoption
Despite their clinical benefits, the high cost associated with point-of-care coagulation testing instruments and consumables remains a major barrier to adoption. Sophisticated devices with advanced technologies such as optical and electrochemical detection are expensive, both in terms of upfront investment and recurring consumable use. This financial burden is especially challenging for smaller healthcare facilities, rural clinics, and institutions in low- to middle-income countries.
In addition, limited reimbursement policies in some regions discourage healthcare providers from investing in these devices. Maintenance costs, training requirements, and lack of standardization in testing practices can also hinder widespread use. As a result, cost remains a critical restraint, preventing universal access to these life-saving diagnostic tools.
Opportunities: Expansion into Home-Based and Remote Coagulation Monitoring
The rise of home healthcare and remote patient monitoring presents a promising opportunity for the point of care coagulation testing market. As healthcare systems shift toward more patient-centric and decentralized care models, compact and user-friendly coagulation testing devices are gaining traction for at-home use. Patients on long-term anticoagulation therapy can benefit from frequent self-monitoring without frequent hospital visits, reducing costs and improving quality of life.
Technological advancements, such as wireless connectivity and mobile health apps, further support remote diagnostics by allowing real-time data sharing between patients and healthcare providers. This facilitates better management of chronic conditions, early intervention, and enhanced compliance. As digital health continues to evolve, manufacturers focusing on portable, connected, and easy-to-use devices will unlock new market segments and drive the next phase of growth in coagulation testing.
SEGMENTATION ANALYSIS:
The consumables segment is anticipated to grow significantly during the forecast period
The consumables segment in the point of care coagulation testing products market is expected to maintain its dominant position during the forecast period, driven by the consistent and recurring need for test strips, reagents, and other disposable components. As these consumables are essential for each test conducted across hospitals, clinics, and home care settings, their usage volume remains significantly high. The growing patient base requiring regular monitoring of coagulation levels—especially those undergoing anticoagulant therapy—further accelerates demand. Additionally, advancements in consumable efficiency and accuracy, along with their relatively low cost compared to instruments, contribute to their widespread adoption and revenue generation.
The instruments segment, while accounting for a smaller share, plays a critical role in supporting point of care testing by enabling fast and accurate blood coagulation analysis. These devices, including portable analyzers and compact benchtop systems, are becoming increasingly sophisticated with features like digital connectivity and integration with electronic health records. However, the high initial investment and lower frequency of replacement restrain rapid growth. Despite this, the rising use of these instruments in emergency care, operating rooms, and remote monitoring is expected to support steady growth, especially as healthcare providers move toward decentralized and technology-driven diagnostic solutions.
REGIONAL ANALYSIS:
The North America region is set to witness significant growth during the forecast period.
North America currently dominates the point of care coagulation testing products market, owing to its advanced healthcare infrastructure, high adoption of innovative medical technologies, and strong presence of key industry players. The region benefits from well-established diagnostic protocols, favorable reimbursement policies, and a high prevalence of cardiovascular and bleeding disorders, which necessitate frequent coagulation monitoring. The widespread availability of point-of-care devices across hospitals, outpatient clinics, and emergency departments supports rapid clinical decision-making, further strengthening market penetration. Moreover, increasing awareness of early disease detection and the growing trend of decentralized healthcare delivery continue to fuel the demand for both consumables and instruments in the region.
Moreover, Asia-Pacific is projected to be the fastest-growing region in the point of care coagulation testing market during the forecast period. This growth is driven by a rising aging population, increasing healthcare expenditures, and a surge in chronic disease prevalence, particularly in countries like China, India, and Japan. The growing focus on expanding rural healthcare access, along with government initiatives to improve diagnostic services, is creating new opportunities for market players. In addition, the shift toward home healthcare and the adoption of portable diagnostic devices are gaining momentum across the region. As awareness and affordability continue to rise, Asia Pacific is poised to become a key market for point of care coagulation testing solutions in the coming years.
COMPETITIVE ANALYSIS:
The global point of care coagulation testing products market is reasonably competitive with mergers, acquisitions, and product launches. See some of the major key players in the market.
F. Hoffmann-La Roche Ltd
Abbott Laboratories
Thermo Fischer Scientific
Siemens Healthineers
International Technidyne Corporation
Beckman Coulter Inc
Instrumentation Laboratory
Sysmex Corporation
Meril Life Sciences Pvt. Ltd
Helena Laboratories
OraSure Technologies
LifeScan IP Holdings LLC
Recent Development of these Companies:
In July 2024, F. Hoffmann-La Roche Ltd launched three new coagulation tests for oral Factor Xa inhibitors—apixaban, edoxaban, and rivaroxaban—in countries accepting the CE mark, enhancing patient care for those on these anticoagulants.
In July 2024, Roche completed the acquisition of LumiraDx's point-of-care technology, aiming to expand access to diagnostic testing in primary care settings.
In 2024, Abbott Laboratories showcased its end-to-end laboratory solutions at the ADLM Clinical Lab Expo, highlighting advancements in point-of-care testing technologies.
In 2024, Thermo Fisher Scientific highlighted its diagnostics innovations across therapeutic areas at ADLM 2024, emphasizing advancements in point-of-care testing solutions.
SCOPE OF THE REPORT:
By Product Type
- Consumables
- Instruments
- Prothrombin Time
- Activated Partial Thromboplastin
- Thromboplastin Time
- Activated Clotting Time
- Mechanical
- Electrochemical
- Optical
- Others
- Hospitals
- Clinical
- Laboratories
- Point-of-Care Testing
- Others
- North America (United States & Canada)
- Europe (Germany, UK, France, Spain, Italy and Rest of Europe)
- Asia-Pacific (China, Japan, India, South Korea, Australia and Rest of Asia-Pacific)
- Latin America (Brazil, Mexico, Argentina and Rest of Latin America)
- Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa and Rest of Middle East and Africa)
It provides a technological development map over time to understand the industry’s growth rate and indicates how the Point of Care Coagulation Testing Products Market is evolving.
The report offers a dynamic method to various factors that drive or restrain the growth of the market and specifies which Point of Care Coagulation Testing Products submarket will be the main driver of the overall market from 2026 to 2034.
It renders a definite analysis of changing competitive dynamics and stipulates the leading players and what are their prospects over the forecast period.
It builds a nine-year estimate based on how the market is predicted to grow and shows what will market shares of the global region change by 2034 and which country will lead the market in 2034.
Table of Contents
183 Pages
- 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global Point of Care Coagulation Testing Products Market - Regional Analysis
- 1.3. Global Point of Care Coagulation Testing Products Market - Segment Analysis
- 1.3.1. Global Point of Care Coagulation Testing Products Market, By Product Type
- 1.3.2. Global Point of Care Coagulation Testing Products Market, By Application
- 1.3.3. Global Point of Care Coagulation Testing Products Market, By Technology
- 1.3.4. Global Point of Care Coagulation Testing Products Market, By End-Use
- 2. Overview And Scope
- 2.1. Market Vision
- 2.1.1. Market Definition
- 2.2. Market Segmentation
- 3. Global Point of Care Coagulation Testing Products Market Overview, By Region: 2020 Vs 2025 Vs 2034
- 3.1. Global Point of Care Coagulation Testing Products Market, By Region (2020 VS 2025 VS 2034)
- 3.2. North Point of Care Coagulation Testing Products Market, By Country (2020 VS 2025 VS 2034)
- 3.3. Europe Point of Care Coagulation Testing Products Market, By Country (2020 VS 2025 VS 2034)
- 3.4. Asia-Pacific Point of Care Coagulation Testing Products Market, By Country (2020 VS 2025 VS 2034)
- 3.5. Latin America Point of Care Coagulation Testing Products Market, By Country (2020 VS 2025 VS 2034)
- 3.6. Middle East & Africa Point of Care Coagulation Testing Products Market, By Country (2020 VS 2025 VS 2034)
- 4. Global Point of Care Coagulation Testing Products Market Dynamics
- 4.1. Market Overview
- 4.1.1. Market Drivers
- 4.1.1.1. Market Driver 1
- 4.1.1.2. Market Drivers 2
- 4.1.2. Market Restraints/ Challenges Analysis
- 4.1.2.1. Market Restraints/ Challenges Analysis 1
- 4.1.2.2. Market Restraints/ Challenges Analysis 2
- 4.1.3. Market Opportunities
- 4.1.3.1. Market Opportunities 1
- 4.1.3.2. Market Opportunities 2
- 4.2. PESTLE Analysis
- 4.2.1. Political Factors
- 4.2.2. Economic Factors
- 4.2.3. Social Factors
- 4.2.4. Technological Factors
- 4.2.5. Legal Factors
- 4.2.6. Environmental Factors
- 4.3. Value Chain Analysis/Supply Chain Analysis
- 4.4. Porter’s Five Forces Model
- 4.4.1. Bargaining Power of Suppliers
- 4.4.2. Bargaining Power of Buyers
- 4.4.3. The threat of New Entrants
- 4.4.4. Threat of Substitutes
- 4.4.5. Intensity of Rivalry
- 4.5. Covid-19 Impact Analysis on Global Point of Care Coagulation Testing Products Market
- ** In – depth qualitative analysis will be provided in the final report subject to market
- 5. Global Point of Care Coagulation Testing Products Market, By Product Type
- 5.1. Overview
- 5.2. Global Point of Care Coagulation Testing Products Market By Product Type (2020 - 2034) (USD Million)
- 5.3. Key Findings for Point of Care Coagulation Testing Products Market - By Product Type
- 5.3.1. Consumables
- 5.3.2. Instruments
- 6. Global Point of Care Coagulation Testing Products Market, By Application
- 6.1. Overview
- 6.2. Global Point of Care Coagulation Testing Products Market By Application (2020 - 2034) (USD Million)
- 6.3. Key Findings for Point of Care Coagulation Testing Products Market - By Application
- 6.3.1. Prothrombin Time
- 6.3.2. Activated Partial Thromboplastin
- 6.3.3. Thromboplastin Time
- 6.3.4. Activated Clotting Time
- 7. Global Point of Care Coagulation Testing Products Market, By Technology
- 7.1. Overview
- 7.2. Global Point of Care Coagulation Testing Products Market By Technology (2020 - 2034) (USD Million)
- 7.3. Key Findings for Point of Care Coagulation Testing Products Market - By Technology
- 7.3.1. Mechanical
- 7.3.2. Electrochemical
- 7.3.3. Optical
- 7.3.4. Others
- 8. Global Point of Care Coagulation Testing Products Market, By End-Use
- 8.1. Overview
- 8.2. Global Point of Care Coagulation Testing Products Market By End-Use (2020 - 2034) (USD Million)
- 8.3. Key Findings for Point of Care Coagulation Testing Products Market - By End-Use
- 8.3.1. Hospitals
- 8.3.2. Clinical
- 8.3.3. Laboratories
- 8.3.4. Point-of-Care Testing
- 8.3.5. Others
- 9. Global Point of Care Coagulation Testing Products Market, By Region
- 9.1. Overview
- 9.2. Global Point of Care Coagulation Testing Products Market, By Region (2020 - 2034) (USD Million)
- 9.3. Key Findings For Point of Care Coagulation Testing Products Market- By Region
- 9.4. Global Point of Care Coagulation Testing Products Market, By Product Type
- 9.5. Global Point of Care Coagulation Testing Products Market, By Application
- 9.6. Global Point of Care Coagulation Testing Products Market, By Technology
- 9.7. Global Point of Care Coagulation Testing Products Market, By End-Use
- 10. Global Point of Care Coagulation Testing Products Market- North America
- 10.1. Overview
- 10.2. North America Point of Care Coagulation Testing Products Market (2020 - 2034) (USD Million)
- 10.3. North America Point of Care Coagulation Testing Products Market, By Product Type
- 10.4. North America Point of Care Coagulation Testing Products Market, By Application
- 10.5. North America Point of Care Coagulation Testing Products Market, By Technology
- 10.6. North America Point of Care Coagulation Testing Products Market, By End-Use
- 10.7. North America Point of Care Coagulation Testing Products Market by Country
- 10.7.1. United States
- 10.7.2. Canada
- 11. Global Point of Care Coagulation Testing Products Market- Europe
- 11.1. Overview
- 11.2. Europe Point of Care Coagulation Testing Products Market (2020 - 2034) (USD Million)
- 11.3. Europe Point of Care Coagulation Testing Products Market, By Product Type
- 11.4. Europe Point of Care Coagulation Testing Products Market, By Application
- 11.5. Europe Point of Care Coagulation Testing Products Market, By Technology
- 11.6. Europe Point of Care Coagulation Testing Products Market, By End-Use
- 11.7. Europe Point of Care Coagulation Testing Products Market by Country
- 11.7.1. Germany
- 11.7.2. UK
- 11.7.3. France
- 11.7.4. Spain
- 11.7.5. Italy
- 11.7.6. Rest of Europe
- 12. Global Point of Care Coagulation Testing Products Market - Asia-Pacific
- 12.1. Overview
- 12.2. Asia-Pacific Point of Care Coagulation Testing Products Market (2020 - 2034) (USD Million)
- 12.3. Asia-Pacific Point of Care Coagulation Testing Products Market, By Product Type
- 12.4. Asia-Pacific Point of Care Coagulation Testing Products Market, By Application
- 12.5. Asia-Pacific Point of Care Coagulation Testing Products Market, By Technology
- 12.6. Asia-Pacific Point of Care Coagulation Testing Products Market, By End-Use
- 12.7. Asia-Pacific Point of Care Coagulation Testing Products Market by Country
- 12.7.1. China
- 12.7.2. Japan
- 12.7.3. India
- 12.7.4. South Korea
- 12.7.5. Australia
- 12.7.6. Rest of Asia-Pacific
- 13. Global Point of Care Coagulation Testing Products Market- Latin America
- 13.1. Overview
- 13.2. Latin America Point of Care Coagulation Testing Products Market (2020 - 2034) (USD Million)
- 13.3. Latin America Point of Care Coagulation Testing Products Market, By Product Type
- 13.4. Latin America Point of Care Coagulation Testing Products Market, By Application
- 13.5. Latin America Point of Care Coagulation Testing Products Market, By Technology
- 13.6. Latin America Point of Care Coagulation Testing Products Market, By End-Use
- 13.7. Latin America Point of Care Coagulation Testing Products Market by Country
- 13.7.1. Brazil
- 13.7.2. Mexico
- 13.7.3. Argentina
- 13.7.4. Rest Of Latin America
- 14. Global Point of Care Coagulation Testing Products Market- Middle East & Africa
- 14.1. Overview
- 14.2. Middle East & Africa Point of Care Coagulation Testing Products Market Size (2020 - 2034) (USD Million)
- 14.3. Middle East & Africa Point of Care Coagulation Testing Products Market, By Product Type
- 14.4. Middle East & Africa Point of Care Coagulation Testing Products Market, By Application
- 14.5. Middle East & Africa Point of Care Coagulation Testing Products Market, By Technology
- 14.6. Middle East & Africa Point of Care Coagulation Testing Products Market, By End-Use
- 14.7. Middle East & Africa Point of Care Coagulation Testing Products Market, By Country
- 14.7.1. Saudi Arabia
- 14.7.2. UAE
- 14.7.3. Israel
- 14.7.4. South Africa
- 14.7.5. Rest of Middle East & Africa
- 15. Global Point of Care Coagulation Testing Products Market- Competitive Landscape
- 15.1. Key Competitive Analysis
- 15.2. Key Strategies Adopted by the Leading Players
- 15.3. Global Point of Care Coagulation Testing Products Market Competitive Positioning
- 15.3.1. Important Performers
- 15.3.2. Emerging Innovators
- 15.3.3. Market Players with Moderate Innovation
- 16. Global Point of Care Coagulation Testing Products Market- Company Profiles
- 16.1. F. Hoffmann-La Roche Ltd.
- 16.1.1. Corporate Summary
- 16.1.2. Corporate Financial Review
- 16.1.3. Product Portfolio
- 16.1.4. Key Development
- 16.2. Abbott Laboratories
- 16.3. Thermo Fischer Scientific
- 16.4. Siemens Healthineers
- 16.5. International Technidyne Corporation
- 16.6. Beckman Coulter Inc
- 16.7. Instrumentation Laboratory
- 16.8. Sysmex Corporation
- 16.9. Meril Life Sciences Pvt. Ltd
- 16.10. Helena Laboratories
- 16.11. OraSure Technologies
- 16.12. LifeScan IP Holdings LLC
- 17. Our Research Methodology
- 17.1. Our Research Practice
- 17.2. Data Source
- 17.2.1. Secondary Source
- 17.2.2. Primary Source
- 17.3. Data Assumption
- 17.4. Analytical Framework for Market Assessment and Forecasting
- 17.5. Our Research Process
- 17.6. Data Validation and Publishing (Secondary Source)
- 18. Appendix
- 18.1. Disclaimer
- 18.2. Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
